The Cigna Group Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- The Cigna Group payments for repurchase of common stock for the quarter ending 2026-06-30 was $280.00M, a 74.82% decline year-over-year.
- The Cigna Group payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- The Cigna Group payments for repurchase of common stock for the quarter ending 2025-12-31 was $1.00B, a 50.49% decline year-over-year.
- The Cigna Group payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- The Cigna Group payments for repurchase of common stock for fiscal 2025 was $3.62B, a 48.52% decline from fiscal 2024.
- The Cigna Group payments for repurchase of common stock for fiscal 2024 was $7.03B, a 207.97% increase from fiscal 2023.
- The Cigna Group payments for repurchase of common stock for fiscal 2023 was $2.28B, a 69.98% decline from fiscal 2022.
- The Cigna Group payments for repurchase of common stock for fiscal 2022 was $7.61B, a 1.74% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $280.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.28B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | $2.11B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.62B 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.64B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.11B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.64B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $1.51B 10-Q · filed 2026-04-30 | $4.52B derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.02B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.03B 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.56B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $990.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $6.18B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.02B 10-Q · filed 2025-05-02 | $5.34B derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $544.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.28B 10-K · filed 2026-02-26 |
| 2023-09-30 | $624.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $3.47B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $154.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $6.35B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $962.00M 10-Q · filed 2024-05-02 | $7.20B derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.61B 10-K · filed 2025-02-27 |
| 2022-09-30 | $3.50B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $7.29B derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $1.01B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.41B derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.37B 10-Q · filed 2023-05-05 | $6.32B derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.42B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.74B 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.61B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $8.01B derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $916.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.43B derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $2.79B 10-Q · filed 2022-05-06 | $5.88B derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.69B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.04B 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.03B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.80B derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $368.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.44B derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $956.00M 10-Q · filed 2021-05-07 | $2.48B derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $447.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.99B 10-K · filed 2022-02-24 |
| 2019-09-30 | $674.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.57B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $404.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $898.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $462.00M 10-Q · filed 2020-05-07 | $494.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $342.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | |
| 2018-03-31 | $310.00M 10-Q · filed 2019-05-02 | |
| 2017-12-31 | $2.73B 10-K · filed 2020-02-27 | |
| 2016-12-31 | $139.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |